Buscar resultados de ensayos clínicos
Angioimmunoblastic Lymphadenopathy With Dysproteinemia - 244 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal Cancer Condición:
Intervenciones: |
Completed |
Nombre del estudio: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Condición:
Intervenciones: |
Active, not recruiting |
Nombre del estudio: Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies Condición:
Intervenciones: |
Completed |
Nombre del estudio: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies Condición:
Intervenciones: |
Completed |
Nombre del estudio: Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma Condición:
Intervenciones: |
Terminated |
Nombre del estudio: Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant Condición:
Intervenciones: |
Active, not recruiting |
Nombre del estudio: Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma Condición:
Intervenciones: |
Completed |
Nombre del estudio: Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma Condición:
Intervenciones: |
Active, not recruiting |
Nombre del estudio: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma Condición:
Intervenciones: |
Completed |
Nombre del estudio: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma Condición:
Intervenciones: |